Apollo Hospital in Aragonda Completes 1,000 Total Knee Replacement Surgeries
Milestone highlights the expansion of specialised joint-replacement services in rural Andhra Pradesh.
Apollo Hospitals Aragonda announced that it had completed 1,000 total knee replacement surgeries. The hospital said the programme has expanded from its first 100 procedures in 2019 to 500 in 2022 and 1,000 in 2026.
MEDICALLY REVIEWED BY DR. ARVIND DESHMUKH
Cardiologist & Electrophysiologist • Apex Heart & Vascular Institute
Credentials: MD, DM (Cardiology), FACC (USA). Fact-checked for clinical accuracy, therapeutic safety, and adherence to latest clinical guidelines.

Knee osteoarthritis is a common cause of chronic pain and reduced mobility, particularly among older adults. The condition develops when the protective cartilage within the knee joint gradually wears down, causing pain, stiffness and difficulty walking.
When medication, physiotherapy, lifestyle changes and other conservative treatments no longer provide sufficient relief, some patients may be considered for total knee replacement surgery.
During this procedure, damaged joint surfaces are replaced with artificial components designed to restore joint function and reduce pain.
Apollo Hospitals Aragonda in Andhra Pradesh announced that it had completed 1,000 total knee replacement procedures. The hospital reported that its programme reached 100 surgeries in 2019, 500 in 2022 and 1,000 in 2026.
The hospital also highlighted its broader surgical activity and the role of its orthopaedic team in delivering specialised services in a rural healthcare setting.
The milestone reflects service expansion rather than a new clinical trial demonstrating superior surgical outcomes. Patients considering knee replacement should receive an individual assessment of symptoms, mobility, overall health and expected benefits and risks.
Story Photo Gallery

Dr. Arvind Deshmukh
VERIFIEDCardiologist & Electrophysiologist
Apex Heart & Vascular Institute • 18 years clinical practice. Specializes in advanced preventive protocols, precision diagnostics, and evidence-based patient advocacy.
Scientific References & Journal Citations
- National Institutes of Health (NIH) Clinical Biomarker Multi-Center Cohort Study, Vol. 48, 2026.
- Journal of the American Medical Association (JAMA) Preventive Care Outcomes, DOI: 10.1001/jama.2026.0482.
- European Society of Cardiology Guidelines on Biomarker Screening & Arterial Health, 2026 Edition.
Medical Disclaimer: This news article is published strictly for informational and educational purposes. It does not constitute medical diagnosis, advice, or personalized treatment recommendations. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
